cagrilintide and tirzepatide together CagriSema vs Tirzepatide: 23% Weight Loss in Phase 3 Trial cagrilintide clinical trials results Comparative

Non-Alcoholic Fatty Liver Disease (NAFLD) Fat accumulation in the liver creates: Oxidative stress Inflammatory signaling Insulin resistance GGT often rises early in NAFLD, sometimes before ALT becomes abnormal

GLP-1 GLP-1GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-11111 GLP-1 GLP-1 GLP-1 GLP-1 1 11GLP-1 1 39,800 2 1 45,000 3 120,000 84 1,800 6 210,000 84 3,200 GLP-1 GLP-1 / () / () / / / / / / / / GLP-1GLP-1OK STEP1 OK STEP2 STEP3 GLP-1GLP-1 Q GLP-1 A GLP-1 Q A GLP-1 Q GLP-1 A GLP-1GLP-11 Q GLP-1 A 1870GLP-1 Q A [] Saxenda [] BMI3027FDAEMAMFDS( ) 1870GLP-1 GLP-1 03-6384-1325 11:0020:00 052-551-7788 11:0020:00

The real secret to success lies in the delivery

With better brain function, youre more likely to engage in movement, eat well, and sleep deeplyall of which are vital for an efficient metabolism